Jump to Navigation
Home

Main menu

  • Home
  • News
  • Markets Map
  • Sentiments
  • Topics
  • Data
  • Comments
  • Images
  • Blog
  • About

Secondary menu

  • Latest News
  • Top Rated
  • Most Popular
  • Archive
  • Discussions
  • Campbell Soup's Solid Results Continue
  • Top producers of electric cars bring their best to expo
  • Taxi fare increase finds support at hearing
  • Ex-child star arrested for tossing bong
  • New CBOE CEO Aims to Take Volatility Franchise Global
  • IIMs, XLRI grads now keen to work with MFIs
  • UK only two-thirds through debt recovery, says BoE's...
  • What Central Banks Can Learn From Volatility
  • Oxford Industries Inc. - Analyst/Investor Day
  • Market turbulence poses first serious test for Abenomics

    Pain Relief

    Sun, 01/23/2011 - 11:29 EDT - Mathew Yglesias
    • Comments
    • crime
    • health care
    • uncat

    Physical pain is a fairly common occurrence in life, so I suppose everyone walks around figuring it’s a sensation they’re familiar with. But something I learned over this past week is that there was a whole new level of pain far beyond anything I’d previously experienced. In my case, it was caused by a small cyst growing beneath one of my wisdom teeth that was pressing on a nerve in my jaw. And, fortunately, it was easy for an oral surgeon to remove. But it hurt a lot while it lasted, and the experience was terrible.
    It made me think back to complaints I’d read and briefly acknowledged over the years about how the “war on drugs” has interfered with medical efforts to treat pain. As Mark Kleiman put it:
    Physicians and their regulators are naturally concerned about the risk of iatrogenic (treatment-induced) drug dependency. Consequently, they have tended to be sparing in their use of opiate and opioid pain relievers, even when the pain involved is extreme and the patient’s short life expectancy, as in the case of terminal cancer patients, makes addiction a largely notional problem. Better professional education has made more recent cohorts of physicians less afraid of over-prescribing painkillers than their older colleagues, but the upsurge of prescription-analgesic abuse (especially of hydrocodone [Vicodin] and oxycodone [Percodan, Oxycontin]) has generated a backlash. [...]
    Current policies are scaring physicians away from treating pain aggressively. Many doctors and medical groups now simply refuse to write prescriptions for any substance in Schedule II, the most tightly regulated group of prescription drugs, including the most potent opiate and opioid pain-relievers and the potent amphetamine stimulants. The opiate-and-stimulant combination the textbooks recommend for treating chronic pain is almost never given in practice for fear (a fear well in excess of the actual risk) of disciplinary action and criminal investigation for a physician prescribing “uppers and downers” together. It’s time to loosen up.
    This is terrible. One of the most interesting findings from the happiness research literature is that human beings are remarkably good at adapting to all kinds of misfortunes. Chronic pain, however, is an exception. People either get effective treatment for their pain, or else they’re miserable. Adaptation is fairly minimum. The upshot is that from a real human welfare perspective, we ought to put a lot of weight on making sure that people with chronic pain get the best treatment possible. Minimizing addiction is a fine public policy goal, but the priority should be on making sure that people with legitimate needs can get medicine.


    • Original article
    • Login or register to post comments
     

    Related

    • Fighting Pain vs Fighting Addiction

    • Competitive Technologies: A Game Changer in Pain Management?

      David Greene submits:Competitive Technologies (CTT) made a new 52-week high at $3.57 yesterday (May 13) on 5X average daily trading volume before doing an understandable retracement, which is continuing today at $2.90.

    • The War On Drugs Versus Developing World Pain Relief

    • 3 Companies Aiming For The $1.2B Opioid Addiction Market

      ByHealthcare Specialist:Prescription pain medication and illicit opiate based drugs are becoming easier than ever before to obtain, in fact about 9% of the population is believed to misuse opiates at some point over the course of their lifetime. With this availability and extremely high potential for abuse comes a horrifying addiction known as opioid dependence.

    • Ontario eye doctor could lose medical license after alleged affair with live-in nanny who was also his patient

      Ontario’s unique zero tolerance policy on sexual abuse by physicians will be put to the test once again on Monday, in the unusual case of a Kingston ophthalmologist whose patient became his live-in nanny, and with whom he is alleged to have had a sexual affair.

    • Pharmaceutical Companies Reformulate Pain Products: How Investors Can Benefit

      Tro Kalayjian submits:In 2009, Purdue Pharma's Oxycontin, an opioid pain reliever, reached annual sales that topped $3 billion. That represents a 300% increase over annual sales in 2001. Clearly, prescriptions for opioid drugs have increased without relent. But along with robust sales there has also been widespread and accelerating abuse.

    • FDA Just Says No To Generic, Crushable Versions Of OxyContin

      (blue_j)

    • Few high risk heart disease patients receive full treatment benefits: paper

      Thousands of people are needlessly dying or suffering from heart disease because many of the proven prevention and treatment methods are simply not being implemented, suggests a group of Canadian doctors and scientists.

    • ‘We know everyone’s not equal’: Queue-jumping probe looks at patients who receive VIP treatment

      There were private-clinic customers pushed to the front of the line for colon-cancer screening, nurses who hoarded pandemic-flu vaccine for their own family members and VIPs given, well, VIP treatment in hospital. An ongoing Alberta public inquiry is offering an unprecedented glimpse at a side of health care usually kept under close wraps: Patients whose influence, fame or money earns them special treatment in an over-taxed system.

    • Pain Therapeutics' Opium for the Masses

      Jim Van Meerten submits: While using Barchart to screen for low-priced stocks hitting the most frequent new highs, I came across Pain Therapeutics (PTIE) and added it to the Barchart Van Meerten Speculative portfolio. The stock was added mainly for technical reasons.

    Latest

    UK only two-thirds through debt recovery, says BoE's Paul Fisher
    UK only two-thirds through debt recovery, says...
    Links 5/24/13
    Links 5/24/13

    User login

    • Create new account
    • Request new password
    • Click on the icon to sign in with your social network login or enter your Bullfax.com login

    Our Blog

    • Tata Steel, ECB, China’s car market and European Corporate Tax in Our News for Today 05/24/2013
    • Pandora: the charm might fade away
    • Japanese Market, Indian Rupee, China’s Stocks and Oil Prices in Our Daily Round-Up for 05/23/2013

    Markets Map

    Markets Map

    Follow Us

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS
    S&P 500: 1650.51 -0.29% FTSE: 6697.08 0% Nikk.: 14612.45 0.88% DAX: 8360.07 0.1% HSI: 22618.67 -0.23% FX: EUR/GBP: 1.1647 USD/EUR: 1.2964 JPY/USD: 101.755 Commodities: Gold: 1388.95

    Bullfax.com - Market News & Analysis 2008-2011
    Contact Us | About Us | Terms & Conditions

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS .

    Secondary menu

    • Latest News
    • Top Rated
    • Most Popular
    • Archive
    • Discussions